Relationships between astrocytic dysfunction and glutamate transport have been well documented in ALS patients; astrocytes from the brains of ALS patients exhibit selective decreases in EAAT-2, the main glutamate transporter in the CNS [230,231,232]. This evidence concerns the gene SLC1A2 and amyotrophic lateral sclerosis.